These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29061078)

  • 21. Clinical Implementation of Pharmacogenetic Testing in a Hospital of the Spanish National Health System: Strategy and Experience Over 3 Years.
    Borobia AM; Dapia I; Tong HY; Arias P; Muñoz M; Tenorio J; Hernández R; García García I; Gordo G; Ramírez E; Frías J; Lapunzina P; Carcas AJ
    Clin Transl Sci; 2018 Mar; 11(2):189-199. PubMed ID: 29193749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of major pharmacogenomics pretest counseling themes: a multisite comparison.
    Wake DT; Bell GC; Gregornik DB; Ho TT; Dunnenberger HM
    Pharmacogenomics; 2021 Feb; 22(3):165-176. PubMed ID: 33461326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterizing Pharmacogenomic-Guided Medication Use With a Clinical Data Repository.
    Mathias PC; Hendrix N; Wang WJ; Keyloun K; Khelifi M; Tarczy-Hornoch P; Devine B
    Clin Pharmacol Ther; 2017 Aug; 102(2):340-348. PubMed ID: 28073152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Impact of Pharmacogenetic-Guided Treatment for Patients Exhibiting Neuropsychiatric Disorders: A Randomized Controlled Trial.
    Olson MC; Maciel A; Gariepy JF; Cullors A; Saldivar JS; Taylor D; Centeno J; Garces JA; Vaishnavi S
    Prim Care Companion CNS Disord; 2017 Mar; 19(2):. PubMed ID: 28314093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interpreting and Implementing Clinical Pharmacogenetic Tests: Perspectives From Service Providers.
    Hachad H; Ramsey LB; Scott SA
    Clin Pharmacol Ther; 2019 Aug; 106(2):298-301. PubMed ID: 31162629
    [No Abstract]   [Full Text] [Related]  

  • 26. Precision Medicine: Lessons Learned From Implementation of a Pharmacogenetics-Based Patient Care Program in a Real-World Setting.
    Kim RB
    Clin Pharmacol Ther; 2019 Nov; 106(5):933-935. PubMed ID: 31520405
    [No Abstract]   [Full Text] [Related]  

  • 27. Awareness and attitude of the public toward personalized medicine in Korea.
    Lee IH; Kang HY; Suh HS; Lee S; Oh ES; Jeong H
    PLoS One; 2018; 13(2):e0192856. PubMed ID: 29451916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of pharmacogenetic testing to prevent adverse drug reactions during statin therapy].
    Rumyantsev NA; Kukes VG; Kazakov RE; Rumyantsev AA; Sychev DA
    Ter Arkh; 2017; 89(1):82-87. PubMed ID: 28252633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A personalized mobile patient guide system for a patient-centered smart hospital: Lessons learned from a usability test and satisfaction survey in a tertiary university hospital.
    Yoo S; Jung SY; Kim S; Kim E; Lee KH; Chung E; Hwang H
    Int J Med Inform; 2016 Jul; 91():20-30. PubMed ID: 27185506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Companion and complementary diagnostics: an important treatment decision tool in precision medicine.
    Jørgensen JT
    Expert Rev Mol Diagn; 2020 Jun; 20(6):557-559. PubMed ID: 32342707
    [No Abstract]   [Full Text] [Related]  

  • 31. Review on Pharmacogenetics and Pharmacogenomics Applied to the Study of Asthma.
    Sánchez-Martín A; García-Sánchez A; Isidoro-García M
    Methods Mol Biol; 2016; 1434():255-72. PubMed ID: 27300544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenomics testing in a community pharmacy: patient perceptions and willingness-to-pay.
    Gibson ML; Hohmeier KC; Smith CT
    Pharmacogenomics; 2017 Feb; 18(3):227-233. PubMed ID: 28112585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An interview with Dr. Edward Abrahams on companion and complementary diagnostics in the era of personalized medicine.
    Abrahams E
    Expert Rev Mol Diagn; 2020 Jun; 20(6):561-563. PubMed ID: 32148107
    [No Abstract]   [Full Text] [Related]  

  • 34. Using CTCs for pharmacogenomic analysis.
    Hart CD; Galardi F; Pestrin M; De Luca F; Risi E; Di Leo A
    Pharmacol Res; 2016 Apr; 106():92-100. PubMed ID: 26921662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is Pharmacogenetic Testing a Vital Tool for Enhancing Therapeutic Management of Patients Worldwide?
    Giacomini KM; van der Graaf PH
    Clin Pharmacol Ther; 2024 Oct; 116(4):885-889. PubMed ID: 39363446
    [No Abstract]   [Full Text] [Related]  

  • 36. Managing Increased Accessibility to Pharmacogenomic Data.
    Haga SB
    Clin Pharmacol Ther; 2019 Nov; 106(5):922-924. PubMed ID: 31482575
    [No Abstract]   [Full Text] [Related]  

  • 37. Patients' and healthcare professionals' views on pharmacogenetic testing and its future delivery in the NHS.
    Fargher EA; Eddy C; Newman W; Qasim F; Tricker K; Elliott RA; Payne K
    Pharmacogenomics; 2007 Nov; 8(11):1511-9. PubMed ID: 18034616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Educating patients and providers through comprehensive pharmacogenetic test reports.
    Haga SB
    Pharmacogenomics; 2017 Jul; 18(11):1047-1050. PubMed ID: 28686141
    [No Abstract]   [Full Text] [Related]  

  • 39. Person-centred mental health care: the challenge of implementation.
    Gask L; Coventry P
    Epidemiol Psychiatr Sci; 2012 Jun; 21(2):139-44. PubMed ID: 22789160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Who Believes They Are "Just Average": Informing the Treatment of Individual Patients Using Population Data.
    Leeder JS
    Clin Pharmacol Ther; 2019 Nov; 106(5):939-941. PubMed ID: 31509232
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.